Apellis Pharmaceuticals, Inc.
(NASDAQ: APLS)

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.

23.070 -

- (-%)
Range 23.070 - 23.070   (-%)
Open 23.070
Previous Close 23.070
Bid Price 18.750
Bid Volume 100
Ask Price 24.200
Ask Volume 267
Volume 747
Value 515
Remark -
Delayed prices. Updated at 29 Jan 2026 22:20.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis